Team powers gene therapy mission, REGENXBIO asserts

Team powers gene therapy mission, REGENXBIO asserts
REGENXBIO commends staff dedication

REGENXBIO recognized its workforce on Employee Appreciation Day, commending the passion and dedication driving its mission to deliver gene therapy solutions for patients and families in need.

The company credited its employees for their daily impact, emphasizing the vital role the team plays in advancing curative gene therapy initiatives. Details about specific achievements or new initiatives were not disclosed. Details are being clarified.

The spotlight on REGENXBIO’s employees comes as the company continues to position itself at the forefront of gene therapy advancements, building on milestones such as the anticipated release of new RGX-202 clinical data at the 2026 MDA Clinical and Scientific Conference. The company’s commitment to fostering talent is further underscored by its emphasis on diversity, as demonstrated by a workforce comprising 56 percent women, reflecting a broader strategy to promote scientific and leadership excellence within the organization.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.